New Study Shows Epidurals During Delivery Offer More than Just Pain Relief

A new study suggests that pregnant people who got an epidural were more than one-third less likely to suffer severe maternal morbidity.
Could Microplastics Be Behind Falling Sperm Counts?

A new study found that testicles of human men contained tiny little shards of plastics, adding to concerns about the impact of our environment on reproduction.
New Guidelines on Syphilis Testing in Pregnancy

The American College of Obstetricians and Gynecologists released new guidelines recommending that all pregnant people be screened for syphilis three times during pregnancy.
Syphilis and Pregnancy — Preventing Congenital Syphilis

The number of babies born with syphilis in the United States is increasing at an alarming rate. There were over 10 times as many babies born with syphilis in 2022 than in 2012.
Understanding Syphilis and How to Prevent It

Syphilis can be treated more easily if it is caught early. But undiagnosed and untreated syphilis can be dangerous. It can cause irreversible health damage and even death.
PID is a leading cause of infertility in women

Pelvic inflammatory disease (PID) is a serious infection in the reproductive organs of women that can lead to infertility or life-threatening complications.
Drug Shortage Means Pregnant Patients Get Delayed Care

As rates of congenital syphilis skyrocket, a severe shortage of the only antibiotic approved to treat syphilis in pregnant women is delaying care for pregnant patients.
Syphilis Rates Surging in Newborns

Cases of infants born with syphilis have soared in recent years. New CDC data reveal that more than 3,700 babies were born with syphilis in 2022—more than 10 times the number born in 2012.
Shortage of Only Drug Approved to Treat Syphilis in Pregnant People

Treating syphilis during pregnancy can help both mother and child, but there is a shortage of Bicillin-L-A, the only antibiotic approved for this population.
FDA Allows Abortion Medication to Be Dispensed at Pharmacies

Following a decision from the U.S. Food and Drug Administration (FDA) released on January 3, 2023, pharmacies will be allowed to offer mifepristone—a drug used for medication abortion—for the first time.